Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →15
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,452
Total Claims
$668K
Drug Cost
759
Beneficiaries
$880
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,404 Physical Medicine and Rehabilitation providers
+122%
Opioid rate vs peers
44.8% vs 20.2% avg
+93%
Cost per patient vs peers
$880 vs $455 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
44.8%
Opioid Rate
4,235
Opioid Claims
$368K
Opioid Cost
15.5%
Long-Acting Rate
This provider's opioid prescribing rate of 44.8% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 8,955 claims · $480K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 21 | $103K |
| Oxycodone Hcl | 98 | $55K |
| Hydrocodone/Acetaminophen | 1,329 | $54K |
| Lidocaine | 290 | $50K |
| Oxycodone Hcl/Acetaminophen | 859 | $44K |
| Naloxegol Oxalate | 64 | $29K |
| Gabapentin | 1,023 | $29K |
| Buprenorphine Hcl/Naloxone Hcl | 25 | $25K |
| Oxycodone Hcl | 730 | $20K |
| Pregabalin | 382 | $18K |
| Buprenorphine | 54 | $17K |
| Erenumab-Aooe | 20 | $16K |
| Diclofenac Sodium | 313 | $15K |
| Morphine Sulfate | 406 | $14K |
| Tizanidine Hcl | 355 | $9,464 |
Prescribing Profile
Patient Profile
68
Avg Age
66%
Female
2.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About